At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 150 enrolled
Drug / intervention
Isovuedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of High Iodine Concentration Contrast Material (Isovue 370) vs Standard Protocol (Isovue 300) in Thoracoabdominal Aortic Computed Tomographic Angiography (CTA) for Radiation Dose Reduction
In Brief
A Phase 4 clinical trial evaluating Isovue for Thoracic Aortic Aneurysm. Completed, enrolled 150 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the contrast agents and imaging techniques used for thoracoabdominal aortic imaging in CT. Imaging parameters and contrast volume are changed and adjusted based on the contrast agent, since contrast agents have varying iodine concentrations. If the contrast iodine concentration is higher, it may be possible to adjust the imaging parameters and lower the overall radiation dose to the patient.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThoracic Aortic Aneurysm
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
First PostedNov 2014
Primary CompletionSep 2015
TodayJul 2026
First PostedNov 14, 2014
Enrollment StartJan 1, 2014
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.6 years ago
Interventions
Isovuedrug
iodine contrast